OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,912,452 | -57.4% | 680,588 | -37.1% | 0.12% | -58.5% |
| Q3 2022 | $4,491,000 | +6.9% | 1,082,103 | +3.6% | 0.28% | +16.9% |
| Q2 2022 | $4,200,000 | -22.4% | 1,044,732 | -4.4% | 0.24% | +1.7% |
| Q1 2022 | $5,411,000 | -22.2% | 1,093,148 | +9.6% | 0.24% | -2.4% |
| Q4 2021 | $6,951,000 | +85.0% | 997,226 | +165.4% | 0.24% | +88.5% |
| Q3 2021 | $3,758,000 | -79.9% | 375,806 | -71.5% | 0.13% | -78.8% |
| Q2 2021 | $18,700,000 | -15.8% | 1,318,737 | -2.6% | 0.61% | -17.1% |
| Q1 2021 | $22,217,000 | -4.3% | 1,353,896 | +20.7% | 0.74% | -8.7% |
| Q4 2020 | $23,218,000 | – | 1,121,628 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |